5 Top Genetics News Stories of 2018

What caught the attention of readers in the genetics market this year? We've compiled a list of our top genetics...

Zymeworks Makes First Dermatology Licensing Deal

This is the first joint antibody discovery and development collaboration for Zymeworks and marks the first dermatology-specific partnership for the...

Pharmaceutical Update: Q3 2018 in Review

With Q3 behind us and Q4 already in full swing, the Investing News Network is providing a look at some...

Genmab Announces Net Sales of DARZALEX (daratumumab) for Third Quarter of 2018

Genmab (Nasdaq:GEN) announced today that worldwide net sales of DARZALEX (daratumumab) as reported by Johnson & Johnson were USD 498...

Geron Cancels Janssen Collaboration, Share Price Drops

Geron and Johnson & Johnson’s subsidiary, Janssen Biotech, have terminated their partnership on development of a drug for two different...

9 Glucose Monitoring Device Stocks

Demand for glucose monitoring devices with the most advanced technology is growing as the number of diabetic patients increases. Here...

Investing in Glucose Monitoring Devices

Diabetes is one of the 10 top killers around the world, and as the healthcare industry races to accommodate growing demand...